We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




European Market for Non-Invasive Blood Pressure Monitoring

By HospiMedica staff writers
Posted on 30 Jun 2008
The European market for non-invasive blood pressure monitoring is witnessing steady growth as a result of improving awareness of the health risks of high blood pressure (BP). More...
These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

There is now a greater acknowledgement of the need to be vigilant against abnormal BP levels, increasing the practice of self-monitoring among the general public. As a result, market participants need to provide efficient sphygmomanometers at lower prices for home use. However, this increased demand is a double-edged sword; while prices of aneroid and digital sphygmomanometers in Europe have dropped due to the increasing presence of sphygmomanometers imported from Chinese or Korean manufacturers, the increased competition has not only impacted on profitability, but also on the intentions of market participants to invest in research and development in order to bring about product innovation. A symbiotic relationship between the established companies and new market participants will help in cutting cost and increasing the market share of the companies.

"Thanks to educational programs and general physician advice, people are making a move towards preventive healthcare to avoid the consequences of hypertension,” said Frost & Sullivan research analyst Akanksha Joshi. "This trend is making blood pressure a household concern, hence providing ample opportunities in the home care market for blood pressure monitoring.”

"Furthermore, environmental issues relating to use of mercury in measuring devices has led to its ban in many European countries, impacting the market share of mercury sphygmomanometers,” added Ms. Joshi. "Given this, companies need to focus on developing accurate blood pressure monitors that can surpass mercury sphygmomanometers as the standard.”

Among the product segments, sphygmomanometers account for the maximum revenues, followed by automated blood pressure monitors and ambulatory blood pressure monitors. The sphygmomanometers market is forecast to grow at a compound annual rate of 8.8% between 2007 and 2014, with market revenues for aneroid and digital sphygmomanometers increasing considerably. Frost & Sullivan has found that the European non-invasive BP monitors market earned revenues of over US$252 million in 2007 and estimates this to reach $444 million in 2014.


Related Links:
Frost & Sullivan

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Digital X-Ray Detector Panel
Acuity G4
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.